Navigation Links
Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
Date:12/14/2008

SAN DIEGO, Dec. 14 /PRNewswire/ -- bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients. Data from the studies were presented this week at the San Antonio Breast Cancer Symposium (SABCS).

The Theros Breast Cancer Index(SM) (BCI) is a combination of Theros H/I(SM) (HOXB13:IL17BR) and Theros MGI(SM) (Molecular Grade Index), two molecular biomarkers that refine and improve risk stratification in patients with estrogen receptor (ER)-positive, lymph node-negative breast cancer.

Data presented at the San Antonio meeting this week provide further evidence that the Theros BCI is a valuable tool for helping oncology medical professionals and patients make information-based decisions regarding breast cancer therapy.

On Thursday, Dennis Sgroi, MD, presented results from a study comparing breast cancer risk recurrence stratification by Oncotype DX versus Theros Breast Cancer Index. Dr. Sgroi and colleagues at Massachusetts General Hospital (MGH) Cancer Center and the Brigham and Womens Hospital, along with colleagues at Indiana University and University of Alabama at Birmingham, looked at tumor samples from 166 estrogen-receptor positive patients for which an Oncotype DX Recurrence Score (RS) of high, intermediate or low was previously reported. The study found that using the combined H/I-MGI biomarkers (Theros BCI) to assess risk recurrence resulted in a smaller intermediate risk group than OncoType Dx (18 percent versus 47 percent, respectively) by re-stratifying a large number of patients with an intermediate Oncotype DX recurrence score into low and high risk groups.

"We know the best way to treat early stage breast cancer patients whose risk recur
'/>"/>

SOURCE bioTheranostics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
3. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
4. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
5. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
6. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
7. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
8. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Larry J. Merlo , President ... will speak before the National Press Club in ... recent move to stop selling tobacco products and its leadership ... health. "Dramatic changes in our health care system ... government," Merlo has said. "CVS Health has a truly unique ...
(Date:9/19/2014)... , Sept. 19, 2014  Lpath, Inc. ... in bioactive lipid-targeted therapeutics, announced today that it ... registered shares of common stock and 3,605,042 unregistered ... purchase price for one registered share of common ... unregistered share of common stock will be $3.475.  ...
(Date:9/19/2014)... 19, 2014  Over 200 runners participated in the ... the Radiation Oncology Institute (ROI), hosted by Radiation Business ... Park in San Francisco.  "Donations are ... of Radiation Business Solutions, "but at this point, ... $70,000 for the ROI this year. This surpasses last ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
... today that it will partner with Direct Relief USA ... shots to community clinic and health center patients who ... organization that works with 1,100 clinics and health centers ... and supplies for their low-income and uninsured patients.  Most ...
... Colo., Sept. 8 N30 Pharmaceuticals, LLC today announced ... a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR). ... administered to human beings. N6022 has the potential to ... human diseases, such as asthma, chronic obstructive pulmonary disease ...
Cached Medicine Technology:CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20 2CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20 3CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20 4N30 Pharma Initiates Phase 1 Trials of Novel Reductase Inhibitor 2
(Date:9/19/2014)... 2014 Are you tired of having ... with seasonal allergies or sinus congestion? Fortunately, an inventor ... , She conceived of Nose Pal to avoid ... nose in public. Since it prevents nasal drip and ... conditions, particularly when cooking or working closely with others. ...
(Date:9/19/2014)... (HealthDay News) -- As kids transition from elementary to ... according to a recent study. But the ... found that verbal and physical bullying declines as students ... and prevention strategies must address all types of bullying ... girls, the researchers said. The study was published recently ...
(Date:9/19/2014)... Phoenix, AZ (PRWEB) September 19, 2014 Hastings ... over 30 years in the industry, announces a record number ... firm handles a wide variety of serious injury cases as ... cases along with dog bite related accident cases and others. ... Hastings and Hastings has stood the test of time when ...
(Date:9/19/2014)... According to a report from HarrisMartin ... Xarelto, named as defendants in several lawsuits filed in ... the court to dismiss those suits because the alleged ... with Philadelphia.* The cases include, for instance, Fontan v. ... Comm. Pls., Philadelphia Cty.), which was brought by a ...
(Date:9/19/2014)... 2014 (HealthDay News) -- Your brain structure could help predict ... study suggests. Researchers at Yale University found those with ... the parietal cortex may be more likely to engage in ... , , The study, funded by the U.S. National Institute ... women living in the Northeast. The researchers sought to determine ...
Breaking Medicine News(10 mins):Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2Health News: Cyberbullying Seems to Ramp Up in Middle School 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Brain Structure Might Help Predict Risky Behavior 2
... Wants Consumers to Go Back to the Basics: Healthy Living ... Chance to Win a Luxury Resort & Spa ExperienceWESTCHESTER, Ill., ... people who make New Year,s resolutions fall off the wagon ... we give ourselves such lofty expectations in the first place? ...
... NEW YORK, March 5 HMS Holdings Corp. ... for government healthcare programs, today announced the promotions ... Christina Dragonetti to Executive Vice President, Commercial Markets; ... Markets. These promotions follow the company,s announcement on ...
... AED industry-leading commitment to research and developmentGrand opening ... the American Academy of Dermatology (AAD)HAYWARD, Calif., March ... SLTM ) today announced the opening of the ... new product development, facilitate research on the innovative ...
... AAD Launches include New Technologies, Innovative Applications and New ... several new launches at the upcoming 67th annual meeting ... CA. Aligned with the company,s strategic imperative to stay ... launches will focus on the company reinforcing its ...
... they,re better able to play sports, be accepted by ... to glasses, contact lenses improve how children feel about ... acceptance among friends, a study of 484 nearsighted children ... spectacle wear on self-perception and the perception of others, ...
... Broadcasts of The Patient Channel and The Newborn ... Wegener Corporation (Nasdaq: WGNR ), a ... data distribution networks worldwide, today announced that the ... division of the iVillage Networks, recently upgraded its ...
Cached Medicine News:Health News:Samantha Harris Launches 'A Toast for Everyday Health' 2Health News:Samantha Harris Launches 'A Toast for Everyday Health' 3Health News:Samantha Harris Launches 'A Toast for Everyday Health' 4Health News:HMS Holdings Corp. Announces Executive Promotions 2Health News:Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center 2Health News:Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center 3Health News:Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting 2Health News:Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting 3Health News:Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting 4Health News:Contact Lenses Boost Kids' Self-Image 2Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 2Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 3Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 4Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 5
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility...
ManuTrain is an active wrist support that has optional features for increased stabilization....
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... 3-Point® Polycentric Hinged Ulnar Deviation Splint uses ... the hand with ulnar deviation at the ... grasp or pinch. Radial and ulnar polycentric ... unimpeded flexion and extension. Padded, malleable finger ...
Medicine Products: